Comparison

Semaglutide vs. tirzepatide: what's the difference?

Both are weekly injectable treatments for weight management. The main difference is how many hormone signals they act on.

In short

The verifiable difference between the two is the mechanism: tirzepatide acts on two receptors (GLP-1 and GIP) and semaglutide on one (GLP-1). Which suits your case depends on your tolerance, medical history, and cost — not the mechanism alone. A licensed provider reviews your case and advises which applies.

Side-by-side comparison

	Semaglutide Injectable	Tirzepatide Injections
Substance	Compounded semaglutide	Compounded tirzepatide
How it acts	One receptor: GLP-1	Two receptors: GLP-1 and GIP
Administration	Subcutaneous injection	Subcutaneous injection
Frequency	Once a week	Once a week
Regulatory status	Compounded in a 503A pharmacy; not FDA-approved	Compounded in a 503A pharmacy; not FDA-approved

Semaglutide Injectable →Tirzepatide Injections →

Not sure which suits you?

A licensed provider reviews your history and advises the option best suited to you.

See if I qualify

SaludBUENO guarantee
Free, fast shipping
Doctor-led plans & follow-up
No hidden fees

hola@saludbueno.com 877.283.6624 - 877.BUENO24 5224 W. State Road 46, PMB #358, Sanford, FL 32771

The evaluation available on the SaludBUENO website does not by itself establish a provider-patient relationship between the person completing it and SaludBUENO. CareValidate, a network of U.S.-licensed providers that follows protocols designed for patient safety, sets exclusionary criteria to determine whether a person does not qualify for GLPs treatments. The answers you submit determine whether your case is eligible for review. If you qualify, a licensed provider will review your case before any prescription.

All claims and benefits described on this site are based on experiences reported by patients enrolled in programs that include compounded medications and consultations with health professionals. Results may vary and depend on multiple factors, including program adherence and the treating provider's recommendations.

Compounded GLP medications are produced in FDA-regulated 503A pharmacies. Although these facilities are highly regulated, compounded medications are not FDA-approved or evaluated for safety, efficacy, or quality. The decision to use compounded medications is based on the licensed provider's clinical judgment, taking into account the telehealth consultation and the patient's medical history.

We encourage anyone interested in compounded medications to consult with a health professional about the specific risks and benefits. SaludBUENO does not produce compounded medications. The product received may look different from the images shown on this site.